Lise Cuzin, Muriel Alvarez. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Cost-Benefit AnalysisDrug ResistanceEnfuvirtideHIV Envelope Protein gp41/economicsHIV Envelope Protein gp41/therapeutic useHIV Fusion Inhibitors/economicsHIV Fusion Inhibitors/therapeutic useHIV Infections/prevention & controlHIV Infections/transmissionHIV-1HumansPeptide Fragments/economicsPeptide Fragments/therapeutic use
Substances: See more » HIV Envelope Protein gp41HIV Fusion InhibitorsPeptide FragmentsEnfuvirtide
Year: 2003 PMID: 14645649 DOI: 10.1056/NEJM200311273492218
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245